ReviewACS applied materials & interfaces2026
Infrared Near-Field Microscopy as a Platform for Nanoscale Biomedical Spectroscopy and Imaging.
Review in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Precision medicine requires tools that can resolve molecular information at the nanoscale, where many early biological and pathological changes arise. Scanning near-field optical microscopy (SNOM) combines molecular vibrational fingerprints with nanoscale spatial resolution, providing a unique platform for overcoming the diffraction limit of conventional optics and enabling in situ chemical characterization of biological samples. This paper systematically reviews the development of SNOM from near-field imaging to spectroscopic platforms such as nano-FTIR and AFM-IR, and summarizes the latest advances in ultrafast, liquid-phase, terahertz, and miniaturized systems. Focusing on representative studies involving proteins, nucleic acids, bacteria, viruses, extracellular vesicles, and cell-material interfaces, this paper discusses SNOM's ability to resolve molecular heterogeneity, structural transitions, and local biochemical interactions in near-natural environments. Additionally, the article analyzes the major challenges facing its clinical translation, including sample preparation, signal-to-noise ratio, measurement speed, quantitative analysis, and standardization, and explores its application potential in AI-assisted analysis, portability, and neuroscience. SNOM is expected to become a key technological platform bridging molecular diagnostics and nanobiological imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.